GM-CSF Sustained Release Formulation for Skin Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cosmetic compositions for skin aging, such as those containing retinol, often cause skin irritation and do not effectively promote sustained skin regeneration or collagen production, as they lack a comprehensive approach to address the biological and photoaging processes that lead to skin deterioration.
Innovation Solution
The use of granulocyte macrophage colony stimulating factor (GM-CSF) in a sustained release formulation to stimulate keratinocyte and fibroblast migration, collagen production, and macrophage infiltration, applied topically or intradermally, to enhance skin repair and regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If retinol is used to improve skin wrinkles and collagen production, then skin regeneration is enhanced, but skin irritation occurs
Solution Approach 1:
The patent changes the active ingredient from retinol to GM-CSF growth factor, fundamentally altering the chemical parameter to achieve skin regeneration without irritation. This parameter substitution resolves the contradiction by finding an alternative substance that provides the desired effect without the harmful side effects.
Solution Approach 2:
The patent employs a sustained-release formulation that delivers GM-CSF over an extended period, replacing the need for frequent reapplication of irritating substances. This approach maintains continuous therapeutic effect while minimizing irritation through controlled delivery rather than repeated exposure.
2Productivity
If cosmetic compositions are applied frequently to promote skin repair, then regeneration effectiveness is improved, but user compliance decreases due to application burden
Solution Approach 1:
The sustained-release formulation ensures continuous delivery of GM-CSF to the skin over an extended period, maintaining therapeutic effectiveness without requiring frequent reapplication. This continuous action principle resolves the contradiction by providing prolonged benefit from a single or limited application.
Solution Approach 2:
The formulation uses a controlled amount of GM-CSF released over time, providing sufficient therapeutic effect without excessive application frequency. This partial action approach maintains effectiveness while reducing the burden of frequent application.
3Productivity
If comprehensive biological approaches are used to address photoaging, then skin regeneration is enhanced, but formulation complexity increases
Solution Approach 1:
GM-CSF serves multiple functions simultaneously: it stimulates keratinocyte migration for epidermal repair, promotes fibroblast activity for dermal collagen production, and enhances overall wound healing. This multi-functionality resolves the contradiction by achieving comprehensive skin regeneration through a single active ingredient rather than multiple complex components.
Solution Approach 2:
The patent combines multiple regenerative effects (keratinocyte migration, fibroblast proliferation, collagen synthesis) into a single formulation containing GM-CSF. This merging of multiple biological functions into one unified approach simplifies the formulation while maintaining comprehensive skin repair capabilities.
Data Source
AI summary
It has been discovered that granulocyte macrophage colony stimulating factor (“GM-CSF”) promotes migration of activated (but not differentiating) keratinocytes to wound sites. It was also discovered that GM-CSF increases the quantity and improves the quality of collagen. This growth factor specifically increases migration of keratinocytes of the “wound” phenotype but does not have significant effects upon differentiated keratinocytes. Examples demonstrate reversal of skin impairment in multiple animal models of diabetic skin imparment when provided in an effective amount over an effective time period. The examples also demonstrate the efficacy of the formulations in cosmetic applications. A preferred formulation is a sustained release formulation that delivers sufficient growth factor to the skin and the underlying tissue thereof to increase the rate of keratinocyte migration, as well as collagen deposition and fibroblast proliferation, in the skin to promote rejuvenation of skin injuries resistant to repair due to underlying disease, such as diabetes, or aging.